Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.975
-0.085 (-8.00%)
At close: Nov 15, 2024, 4:00 PM
0.980
+0.005 (0.49%)
After-hours: Nov 15, 2024, 7:16 PM EST
Lexicon Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for LXRX stock has a target of 6.00, which predicts an increase of 515.26% from the current stock price of 0.98.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LXRX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +515.26% | Nov 13, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +515.26% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +515.26% | Nov 1, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 1, 2024 |
Financial Forecast
Revenue This Year
15.80M
from 1.20M
Increased by 1,212.46%
Revenue Next Year
50.42M
from 15.80M
Increased by 219.10%
EPS This Year
-0.70
from -0.80
EPS Next Year
-0.61
from -0.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 39.2M | 63.5M | 188.5M | ||
| Avg | 15.8M | 50.4M | 120.2M | ||
| Low | 9.6M | 37.3M | 70.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3,152.9% | 302.0% | 273.8% | ||
| Avg | 1,212.5% | 219.1% | 138.3% | ||
| Low | 696.0% | 136.2% | 40.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.65 | -0.51 | -0.14 | ||
| Avg | -0.70 | -0.61 | -0.47 | ||
| Low | -0.73 | -0.74 | -0.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.